Atomwise Company
Atomwise uses artificial intelligence for drug discovery. We design new molecules for the hardest targets. Our discoveries help our partners deliver better medicines faster.
Investors
Connections from
Founded Date:
2012-01-01
Technology:
['BioTech & HealthTech']
Investor Type:
For Profit
Funding Status:
Early Stage Venture
Total Funding:
176645000.0
Employee Number:
94
Headquarters:
United
Last Funding Date:
2020-10-06
Investors Number:
22.0
Last Funding Type:
Grant
Estimated Revenue:
2.3
Industry:
Application Software